Office of Digital Transformation’s New Focus on Technology… – FDA. gov
By: Vid Desai, Chief Information Officer and Jessica N. Berrellez, Executive Officer
Electronic transformation is a continuous journey that touches every part of an organization. The U. S. Food and Drug Administration established the Workplace of Digital Transformation (ODT) in September 2021 plus elevated the Chief Info Officer (CIO) reporting structure to the particular FDA Commissioner. The FDA is implementing a technology, data, cybersecurity, and business process modernization strategy to advance our public health mission – known as our FDA Modernization Framework. ODT is increasingly partnering with centers across the agency to use technology and data for better company outcomes. While technology was previously a secondary function, it is now a driver of operational effectiveness plus workforce performance. It is not enough to build or buy the latest tools and technologies – you must have the management infrastructure and people to implement, secure, and maintain them to deliver business value in a fast-changing environment.
The increased shift in order to virtual work during the COVID-19 pandemic highlighted the value of the shared, cross-agency approach to IT- with IT leadership more critical than ever in enabling the particular continuity of operations. It also underscored the importance of ODT’s leadership competencies and strategic vision with regard to leading technology modernization. As we progress, the FDA must have strong, adaptive leaders at the helm associated with ODT plus center IT programs. Our organization must also have a pipeline of diverse future technologies leaders, operating in a continuous learning mindset to quickly adapt to ever-increasing demand and complexity.
This month we introduced the particular technology-focused Leadership Modernization Action Plan (LMAP), the next milestone within the FDA’s enterprise transformation journey. The particular LMAP lays out our own plans to strengthen the technology management capabilities in order to effectively drive change in the business, technology, data, plus cybersecurity levels. The LMAP is the final piece of the particular agency’s technologies Modernization Frameworks that are in action today and places people, and technology leaders, on the forefront of these efforts. This investment in developing our mission-driven staff will enable us to realize our bold change vision successfully.
The three elements of the LMAP are usually to:
- Create an environment where business and THIS programs are aligned plus collaborate to achieve company priorities and leverage IT opportunities in order to enhance outcomes.
- Develop plus operationalize a good IT strategy that is reflective of business needs.
- Develop a pipeline of new technology frontrunners who can maintain strategic continuity through command and organizational change.
Through modernization we aim to cultivate the FDA’s technology leadership ability to support our own digital modification goals. ODT’s increased focus on people, leadership, and organizational culture in the particular context of modernization attempts will foster a setting that will attracts plus retains top talent. We will also work to develop technology market leaders and change agents at every level of the organization. ODT will start along with small pilots to test innovative technology talent and leadership development strategies. The LMAP highlights current or even upcoming fliers focused on technologies change management training, technology workforce upskilling, and enhancing ODT’s hiring and compensation strategy.
In today’s digital world, all business activities depend on THIS services. Engaged IT commanders can understand business operations from an unique vantage point plus aligning IT strategy with business objectives ensures that our limited IT resources focus on the right company priorities. Investing in leadership as a critical component of ODT’s technologies and company transformation will certainly better prepare us to act as tactical partners in tackling the particular agency’s most complex challenges. With the LMAP, ODT has a well-grounded framework in order to drive the particular modernization that will help advance the FDA’s general public health objective.